Panacea Biotec shareholders and shareholding pattern
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Last close ₹311.45down ₹15.35 (4.70%)BSE ₹311.40
Share price at the NSE close on 23 Oct 2026. Previous close ₹326.80.
52-week range of traded prices to 23 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,908 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 31 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 31 May 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 82,88547.4% delivered
Who owns Panacea Biotec, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters72.48%
- Foreign institutions2.75%
- Indian institutions2.47%
- Individuals and others22.30%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 20 Jan | Mar 2017Filed 22 Apr | Jun 2017Filed 20 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 17 Jan | Mar 2018Filed 18 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 18 Oct | Dec 2018Filed 17 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 6 Aug | Sep 2019Filed 17 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 8 May | Jun 2020Filed 18 Jul | Sep 2020Filed 16 Oct | Dec 2020Filed 15 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 17 Jul | Sep 2021Filed 11 Oct | Dec 2021Filed 10 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 21 Oct | Dec 2022Filed 19 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 17 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.60% | 74.60% | 74.60% | 74.60% | 74.07% | 74.07% | 74.07% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.46% | 72.87% | 72.49% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | |
| Indian promoters | 74.60% | 74.60% | 74.60% | 74.60% | 74.07% | 74.07% | 74.07% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.59% | 73.46% | 72.87% | 72.49% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 25.40% | 25.40% | 25.40% | 25.40% | 25.93% | 25.93% | 25.93% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.41% | 26.54% | 27.13% | 27.51% | 27.52% | 27.52% | 27.52% | 27.52% | 27.52% | 27.52% | 27.52% |
| Promoter shares pledgedShare of the promoters' own shares | 35.03% | 35.03% | 35.03% | 35.03% | 35.28% | 35.28% | 35.28% | 35.51% | 35.51% | 35.51% | 69.36% | 69.36% | 69.36% | 69.36% | 69.36% | 69.36% | 69.36% | 94.27% | 94.27% | 94.27% | 94.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 | 6,12,50,746 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Panacea Biotec promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Dr. Rajesh Jain, 49.01%. The filing names 7 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Dr. Rajesh JainIndividuals and Hindu undivided families | 49.01% | 3,00,17,312 |
| Mr. Sandeep JainIndividuals and Hindu undivided families | 15.27% | 93,51,924 |
| Mrs. Nirmala JainIndividuals and Hindu undivided families | 4.10% | 25,11,000 |
| First Lucre Partnership Co.Indian companies, trusts and others | 3.68% | 22,55,815 |
| Rajesh Jain (HUF)** (Karta : Rajesh Jain)Individuals and Hindu undivided families | 0.33% | 2,00,000 |
| Second Lucre Partnership Co.Indian companies, trusts and others | 0.09% | 57,639 |
| Mr. Ashish JainIndividuals and Hindu undivided families | 0.00% | 500 |
No promoter shares are reported as pledged.
Largest public holders of Panacea Biotec, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 20 Jan | Mar 2017Filed 22 Apr | Jun 2017Filed 20 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 17 Jan | Mar 2018Filed 18 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 18 Oct | Dec 2018Filed 17 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 6 Aug | Sep 2019Filed 17 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 8 May | Jun 2020Filed 18 Jul | Sep 2020Filed 16 Oct | Dec 2020Filed 15 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 17 Jul | Sep 2021Filed 11 Oct | Dec 2021Filed 10 Jan | Mar 2022Filed 18 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 21 Oct | Dec 2022Filed 19 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 17 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 17 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Massachusetts Institute of TechnologyForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.12% | 1.71% | 1.81% |
| Viral Amal ParikhOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.47% | 1.47% | 1.47% |
| Magic Square Hospitality Services LLPCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.68% | 2.18% | – | – | – | – | – | – | – |
| Serum Institute of India Pvt. Ltd.Companies | – | – | 14.58% | 14.58% | 14.58% | 9.43% | 9.43% | 9.43% | 9.43% | 9.43% | 9.43% | 9.43% | 9.43% | 9.48% | 9.57% | 8.03% | 5.47% | 4.98% | 8.59% | 8.59% | 8.59% | 8.01% | 8.01% | 8.01% | 7.61% | 7.60% | 6.97% | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – |
| Adar Cyrus PoonawallaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | 5.16% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | 5.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| APOORVA REALTORS & FINVEST PVT. LTD.Other non-institutions | – | – | – | 1.19% | – | 1.24% | 1.24% | 1.24% | 1.24% | 1.14% | – | – | – | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Apporva Realtors & Finvest Private LimitedOther non-institutions | – | – | – | – | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Gain Premium LimitedOther non-institutions | 1.04% | 1.04% | – | 1.04% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Serum Institute of India LimitedOther non-institutions | 14.58% | 14.58% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.